SOMATROPIN

Search structure
Trade Names:
Synonyms:
HGH
Status: Approved (1976)
Entry Type: Protein
Molecule Category: UNKNOWN
ATC: H01AC01
UNII: NQX9KB6PCL

Pharmacology

Action Mechanism of Action Reference
AGONIST Growth hormone receptor agonist

Indications

Mesh Heading Maximum Phase Mesh ID Reference
Short Bowel Syndrome 4 D012778 ClinicalTrials
Dwarfism 4 D004392 ClinicalTrials
Dwarfism 4 D004392 ClinicalTrials
HIV Infections 4 D015658 ClinicalTrials
Heart Failure 3 D006333 ClinicalTrials
Endocrine System Diseases 3 D004700 ClinicalTrials
Fetal Growth Retardation 3 D005317 ClinicalTrials
Obesity 3 D009765 ClinicalTrials
Cardiovascular Diseases 3 D002318 ClinicalTrials
Hypopituitarism 3 D007018 ClinicalTrials
Diabetes Mellitus 3 D003920 ClinicalTrials
HIV Wasting Syndrome 3 D019247 ClinicalTrials
Growth Disorders 3 D006130 ClinicalTrials
Cystic Fibrosis 3 D003550 ClinicalTrials
Noonan Syndrome 3 D009634 ClinicalTrials
Osteogenesis Imperfecta 3 D010013 ClinicalTrials
Arthritis, Juvenile 3 D001171 ClinicalTrials
Kidney Failure, Chronic 3 D007676 ClinicalTrials
Spinal Cord Injuries 3 D013119 ClinicalTrials
Brain Injuries 2 D001930 ClinicalTrials
Muscular Atrophy, Spinal 2 D009134 ClinicalTrials
Amyotrophic Lateral Sclerosis 2 D000690 ClinicalTrials
Pseudohypoparathyroidism 2 D011547 ClinicalTrials
Tibial Fractures 2 D013978 ClinicalTrials
Aging 2 D000375 ClinicalTrials
Mucopolysaccharidosis VI 2 D009087 ClinicalTrials
Mucopolysaccharidosis II 2 D016532 ClinicalTrials
Crohn Disease 2 D003424 ClinicalTrials
Infertility 2 D007246 ClinicalTrials
Liver Cirrhosis 2 D008103 ClinicalTrials
Pseudohypoparathyroidism 2 D011547 ClinicalTrials
Non-alcoholic Fatty Liver Disease 2 D065626 ClinicalTrials
Tendinopathy 2 D052256 ClinicalTrials
Mucopolysaccharidoses 2 D009083 ClinicalTrials
Osteoarthritis, Knee 2 D020370 ClinicalTrials
Burns 2 D002056 ClinicalTrials
Sarcopenia 2 D055948 ClinicalTrials
Fractures, Bone 2 D050723 ClinicalTrials
Muscular Dystrophy, Facioscapulohumeral 1 D020391 ClinicalTrials
Infertility, Female 1 D007247 ClinicalTrials
Cognitive Dysfunction 1 D060825 ClinicalTrials

Adverse Reactions

SOC By Demographic Distribution
System Organ Classification (SOC)
Relative Frequency (%)
Injury, poisoning and procedural complications
14.18
General disorders and administration site conditions
14.01
Investigations
13.81
Nervous system disorders
9.0
Musculoskeletal and connective tissue disorders
6.93
Psychiatric disorders
4.94
Respiratory, thoracic and mediastinal disorders
4.36
Gastrointestinal disorders
4.22
Skin and subcutaneous tissue disorders
4.03
Vascular disorders
3.43
Metabolism and nutrition disorders
3.25
Product issues
3.18
Infections and infestations
3.13
Endocrine disorders
2.11

Cross References

Resources Reference
CAS NUMBER 12629-01-5
ChEMBL CHEMBL1201621
FDA SRS NQX9KB6PCL
CONTENTS